WebJun 28, 2024 · GARDEN CITY, N.Y., June 28, 2024 — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond … WebApr 10, 2024 · Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. Beyond Air, Inc. Fundamentals …
Beyond Air, Inc.
WebFeb 10, 2024 · Beyond Air, Inc. ( NASDAQ: XAIR) Q3 2024 Earnings Conference Call February 9, 2024 4:30 PM ET Company Participants Edward Barger - Head, Investor Relations Steve Lisi - Chairman and CEO... WebNov 12, 2024 · Beyond Air, Inc. ( NASDAQ: XAIR) Q2 2024 Earnings Conference Call November 11, 2024 4:30 PM ET Company Participants Maria Yonkoski - Head of Investor … gumtree desk lancashire
Beyond Air (Nasdaq:XAIR) - Stock Price, News & Analysis - Simply Wall St
WebOct 19, 2024 · Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, stated, “To our knowledge, ours is the first and only program testing the concept of injecting high concentration NO gas into... WebJun 15, 2024 · “The Beyond Air team continues to execute with this most recent accomplishment. The global need to discover a safe and effective treatment for this virus is painfully apparent. We look forward to keeping everyone abreast of the study’s progress over the coming weeks,” said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. WebFeb 22, 2024 · Beyond Air is a medical device and biopharmaceutical company dedicated to harnessing the power of nitric oxide through its revolutionary NO Generator and Delivery System, LungFit, that uses NO... gumtree delivery scam